FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to a method of treating and/or preventing a neurodegenerative disorder or disease in a subject suffering from it. Method of treating and/or preventing a neurodegenerative disorder or disease in a subject suffering from it involves administering to said subject a composition Vertigoheel® in amount of 1 ml/kg to 2 ml/kg of the body weight of the treated subject a day.
EFFECT: said method enables effective treatment and/or prevention of neurodegenerative disorder or disease.
8 cl, 12 dwg, 1 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DONECOPRID AS A NEUROPROTECTIVE AGENT IN THE TREATMENT OF NEURODEGERATIVE DISEASES | 2019 |
|
RU2800802C2 |
| COMPOSITION, CONTAINING MIXED EXTRACT OF MULBERRY AND PORIA COCOS SKIN, INTENDED FOR PREVENTION, RELIEF AND TREATMENT OF NEURODEGENERATIVE DISORDERS | 2015 |
|
RU2679654C2 |
| COMPOSITION, CONTAINING EXTRACT OF PORIA COCOSUM TISSUE, INTENDED FOR PREVENTION, RELIEF AND TREATMENT OF NEURODEGENERATIVE DISORDERS | 2015 |
|
RU2678982C2 |
| THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE AND METHOD OF TREATING ALZHEIMER'S DISEASE | 2011 |
|
RU2536232C2 |
| DPP-IV INHIBITORS FOR TREATMENT OF NEURODEGENERATION AND COGNITIVE DISORDERS | 2005 |
|
RU2394570C2 |
| 5-HT RECEPTOR AGONIST COMPOUNDS FOR TREATING COGNITIVE DISORDERS | 2010 |
|
RU2569056C2 |
| COMPOSITIONS CONTAINING VORTIOXETINE AND DONEPEZIL | 2013 |
|
RU2635528C2 |
| MEDICATION FOR TREATING ALZHEIMER'S DISEASE AND METHOD OF TREATING ALZHEIMER'S DISEASE | 2010 |
|
RU2542445C2 |
| TREATMENT OF NEUROLOGICAL DYSFUNCTION BY USING FRUCTOPYRANOSE AND ERYTHROPOIETIN SULFAMATES | 2002 |
|
RU2317086C2 |
| APPLICATION OF PROTEIN YB-1 AND ITS FRAGMENTS FOR PRODUCTION OF MEDICATIONS IN TREATMENT OF ALZHEIMER'S DISEASE | 2013 |
|
RU2561050C2 |
